Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05870943 · ClinicalTrials.gov registry record · NA
Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study
A NA study of Obesity, sponsored by True You Weight Loss.
- Active
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05870943: Active NA study of Obesity, sponsored by True You Weight Loss.
NCT05870943 is a NA study of Obesity that is active but no longer recruiting, run by True You Weight Loss. The registered enrollment target is 48 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05870943, a NA study of Obesity, is active but no longer recruiting, sponsored by True You Weight Loss.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the clinical safety, durability, and weight loss outcomes of the hybrid argon plasma coagulation + endoscopic sleeve gastroplasty (HAPC-ESG) procedure when compared to traditional endoscopic sleeve gastroplasty (ESG) alone. ESG was proven to be feasible in human subjects in 2013 and since then has become the most commonly performed endoscopic bariatric remodeling procedure. However, this procedure may be enhanced with the addition of the hybrid argon plasma coagulation (HAPC) technique, leading to enhanced weight loss, durability, and metabolic benefits. Argon plasma coagulation (APC) is a method of non-contact thermal hemostasis initially created to assist in inducing hemostasis utilizing a high-frequency current to the targeted area. This is a validation study of a pilot randomized control trial which will evaluate the safety, durability, and effects on weight loss of the combined HAPC-ESG approach when compared to traditional ESG alone.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Sleeve Gastroplasty
- PROCEDURE Hybrid Argon Plasma Coagulation
Study Locations (1)
North Carolina
- True You Weight Loss - Cary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2025-05 |
| Phase | NA |
What the registry record for NCT05870943 still lists
NCT05870943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Endoscopic Sleeve Gastroplasty is the first listed.
NCT05870943 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05870943 about?
NCT05870943 is a clinical study titled "Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study". The purpose of this research is to evaluate the clinical safety, durability, and weight loss outcomes of the hybrid argon plasma coagulation + endoscopic sleeve gastroplasty (HAPC-ESG) procedure when compared to traditional endoscopic sleeve gastroplasty (ESG) alone. ESG was proven to be feasible in...
What is the current status of trial NCT05870943?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-05-18. Estimated completion is 2025-05.
What conditions does trial NCT05870943 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT05870943?
The interventions under investigation include: Endoscopic Sleeve Gastroplasty (PROCEDURE), Hybrid Argon Plasma Coagulation (PROCEDURE).
Who is sponsoring clinical trial NCT05870943?
This trial is sponsored by True You Weight Loss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05870943 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05870943's enrollment target sits among peer trials
48 734th of 1053 higher than 312 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI